{
    "id": "medical_genetics-087",
    "question": "Mutations that cause achondroplasia exert an effect which can be classified as:",
    "options": {
        "A": "dominant negative.",
        "B": "gain-of-function.",
        "C": "haploinsufficiency.",
        "D": "loss-of-function."
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, let's consider the characteristics of achondroplasia and the nature of the mutations that cause it. Achondroplasia is a genetic disorder that affects bone growth, resulting in short-limbed dwarfism. The most common cause of achondroplasia is a gain-of-function mutation in the FGFR3 gene. This type of mutation leads to the constitutive activation of the receptor, resulting in unregulated signal transduction and inappropriate development of cartilage. As a result, the growth of cartilage is inhibited, leading to the characteristic short-limbed dwarfism of achondroplasia. Given this understanding, we can evaluate the options: Option A, dominant negative, refers to a type of mutation that results in the suppression of the function of a normal allele, typically by forming a dysfunctional protein. This is not the case in achondroplasia, where the mutation leads to the constitutive activation of the receptor, not suppression. Option B, gain-of-function, describes a type of mutation that results in the overactivation or enhanced function of a protein. This is consistent with the gain-of-function mutation in the FGFR3 gene that causes achondroplasia, as it leads to unregulated signal transduction and inappropriate cartilage development. Option C, haploinsufficiency, refers to a situation where a single normal allele is not sufficient to maintain a normal phenotype. While haploinsufficiency is a mechanism underlying some genetic disorders, it is not the primary mechanism underlying achondroplasia. Option D, loss-of-function, describes a type of mutation that results in the reduction or elimination of a protein's function. This is not the case in achondroplasia, where the mutation leads to the constitutive activation of the receptor, not the loss of function. Based on this analysis, the correct answer is B, gain-of-function, as the mutations that cause achondroplasia result in the constitutive activation of the FGFR3 receptor, leading to unregulated signal transduction and inappropriate cartilage development.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "Pediatrics_Nelson_952",
            "title": "Pediatrics_Nelson",
            "content": "AD disorders sometimes appear in a child of unaffectedparents because of a spontaneous mutation. Known in some cases to be associated with advanced paternal age(>35 years of age), spontaneous mutations may account formost individuals with some disorders. Approximately 80%of patients with achondroplasia have a spontaneous mutation in the fibroblast growth factor receptor type 3 (FGFR3)gene. The following are examples of autosomal dominantdisorders. Table 47-1 Autosomal Dominant Diseases DISEASE FREQUENCY COMMENTS Achondroplasia Thanatophoric dysplasia Crouzon syndrome with acanthosis nigricans Nonsyndromic craniosynostosis \u223c1:12,000 Mutations are in the gene for fibroblast growth factor receptor-3 on chromosome 4p16.3. 40% of cases are new mutations (different mutations in the same gene cause achondroplasia, thanatophoric dysplasia, Crouzon syndrome with acanthosis, and nonsyndromic craniosynostosis)"
        },
        {
            "id": "InternalMed_Harrison_28982",
            "title": "InternalMed_Harrison",
            "content": "that the UPR is a component of pathology of these conditions. Some CDs are caused by mutations in genes that affect early development of cartilage and related structures. The most common form of short-limbed dwarfism, achondroplasia, is caused by mutations in the gene for a receptor for a fibroblastic growth factor (FGFR3). The mutations in the FGFR3 gene causing achondroplasias are unusual in several respects. The same single-base mutation in the gene that converts glycine to arginine at position 380 in the FGFR3 gene is present in over 90% of patients. Most patients harbor sporadic new mutations, and therefore, this nucleotide change must be one of the most common recurring mutations in the human genome. The mutation causes unregulated signal transduction through the receptor and inappropriate development of cartilage. Mutations that alter other domains of FGFR3 have been found in patients with the more severe disorders of hypochondroplasia and thanatophoric dysplasia and in a few"
        },
        {
            "id": "Pathology_Robbins_4744",
            "title": "Pathology_Robbins",
            "content": "Achondroplasia, the most common skeletal dysplasia and a major cause of dwarfism, is an autosomal dominant disorder resulting from retarded cartilage growth. The disease is caused by gain-of-function mutations in fibroblast growth factor receptor 3 (FGFR3). Normally, FGF inhibits endochondral growth. FGFR3 mutation results in a constitutively active receptor, thereby exaggerating this effect and suppressing growth. Approximately 90% of cases stem from new mutations, almost all of which occur in the paternal allele. Affected individuals have shortened proximal extremities, a trunk of relatively normal length, and an enlarged head with bulging forehead and conspicuous depression of the root of the nose. The skeletal abnormalities are usually not associated with changes in longevity, intelligence, or reproductive status."
        },
        {
            "id": "Obstentrics_Williams_1352",
            "title": "Obstentrics_Williams",
            "content": "he FGFR3 chondrodysplasias include achondroplasia and thanatophoric dysplasia. Achondroplasia, also called heterozygous achondroplasia, is the most common nonlethal skeletal dysplasia. An impressive 98 percent of cases are due to a speciic point mutation in the FGFJ gene. It has an autosomal dominant inheritance, and 80 percent of cases result from a new mutation. Achondroplasia is characterized by long bone shortening that is predominantly rhizomelic, an enlarged head with frontal bossing, depressed nasal bridge, exaggerated lumbar lordosis, and a trident configuration of the hands. Intelligence is typically normal. Sonographically, the femur and humerus measurements may not lie below the 5th percentile until the early third trimester. hus, this condition is usually not diagnosed until late in pregnancy. In homozygotes, which represent 25 percent of the ofspring of heterozygous parents, the condition is characterized by greater long bone shortening and is lethal."
        },
        {
            "id": "Obstentrics_Williams_1734",
            "title": "Obstentrics_Williams",
            "content": "can arise from diferent mutations in the same gene. As an example, mutations in the ibroblast growth actor receptor 3 (FGF3) gene may result in several diferent skeletal disorders, including achondroplasia and thanatophoric dysplasia, both of which are discussed in Chapter 10 (p. 210). If only one copy of a gene pair determines the phenotype, that gene is considered to be dominant. Carriers have a 50-percent chance of passing on the afected gene with each conception. A gene with a dominant mutation generally speciies the phenotype in preference to the normal gene. That said, not all individuals will necessarily manifest an autosomal dominant condition the same way. Factors that afect the phenotype of an autosomal dominant condition include penetrance, expressivity, and occasionally, presence of codominant genes."
        },
        {
            "id": "Neurology_Adams_10197",
            "title": "Neurology_Adams",
            "content": "Achondroplasia This dominantly inherited form of dwarfism is caused by a mutation in one of the fibroblastic growth factors, which causes a failure of conversion of fetal cartilage to bone at the growth plate. It occasionally results in great thickening of the vertebral bodies, neural arches, laminae, and pedicles because of increased periosteal bone formation. The spinal canal is narrowed in the thoracolumbar region, often with kyphosis, leading sometimes to a progressive spinal cord or cauda equina syndrome. Another complication, which results from a small foramen magnum, is hydrocephalus (or markedly widened subarachnoid spaces). In young children, a syndrome of central apnea and spasticity of the legs is characteristic. These complications may require ventricular shunting. Narrowing of the lumbar canal tends to present later in life."
        },
        {
            "id": "Pediatrics_Nelson_953",
            "title": "Pediatrics_Nelson",
            "content": "Neurofibromatosis 1 1:3500 About 50% of cases result from new mutations in the gene for neurofibromin, a tumor suppressor gene located at 17q11.2. Expression is quite variable Huntington disease (HD) Variable in populations, The disease is caused by a (CAG) repeat expansion in the \u201cHuntington\u201d 1:5000\u20131:20,000 protein gene on chromosome 4p16.3 Marfan syndrome (FBN-1) 1:10,000 The syndrome is caused by mutations in the fibrillin 1 (FBN 1) gene on chromosome 15q21.1; there is variable expression Caused by a defect in cartilage-derived bone, achondroplasia (ACH) is the most common skeletal dysplasia in humans. The bony abnormalities lead to short stature, macrocephaly, a flat midface with a prominent forehead, and rhizomelic shortening of the limbs. The disorder occurs in approximately 1 in 12,000 births."
        },
        {
            "id": "Cell_Biology_Alberts_6008",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 21\u201362 Achondroplasia. this type of dwarfism occurs in one of 10,000\u2013100,000 births; in more than 99% of cases it results from a mutation at an identical site in the genome, corresponding to amino acid 380 in the FGF receptor FGFr3 (a glycine in the transmembrane domain). the mutation is dominant, and almost all cases are due to new, independently occurring mutations, implying an extraordinarily high mutation rate at this particular site in the genome. the defect in FGF signaling causes dwarfism by interfering with the growth of cartilage in developing long bones. (From Velasquez\u2019s painting of Sebastian de Morra. \u00a9 Museo del prado, Madrid.) Figure 21\u201363 Myostatin limits muscle growth. a wild-type whippet dog and a bully whippet that lacks myostatin. (a, from http://www.merlinanimalrescue.co.uk/dogs/?m=201211; B, from http://animalslook.com/schwarzenegger-dog/.)"
        },
        {
            "id": "InternalMed_Harrison_28896",
            "title": "InternalMed_Harrison",
            "content": "Achondrodysplasia This is a relatively common form of short-limb dwarfism that occurs in 1 in 15,000 to 1 in 40,000 live births. The disease is caused by a mutation of the fibroblast growth factor receptor 3 (FGFR3) gene that results in a gain-of-function state. Most cases are sporadic mutations. However, when the disorder appears in families, the inheritance pattern is consistent with an autosomal dominant disorder. The primary defect is abnormal chondrocyte proliferation at the growth plate that causes development of short, but proportionately thick, long bones. Other regions of the long bones may be relatively unaffected. The disorder is manifest by the presence of short limbs (particularly the proximal portions), normal trunk, large head, saddle nose, and an exaggerated lumbar lordosis. Severe spinal deformity may lead to cord compression. The homozygous disorder is more serious than the sporadic form and may cause neonatal death. Pseudoachondroplasia clinically resembles"
        },
        {
            "id": "InternalMed_Harrison_28897",
            "title": "InternalMed_Harrison",
            "content": "lordosis. Severe spinal deformity may lead to cord compression. The homozygous disorder is more serious than the sporadic form and may cause neonatal death. Pseudoachondroplasia clinically resembles achondrodysplasia but has no skull abnormalities."
        },
        {
            "id": "Pathology_Robbins_4745",
            "title": "Pathology_Robbins",
            "content": "Thanatophoric dysplasia, the most common lethal form of dwarfism, results from diminished proliferation of chondrocytes and disorganization in the zone of proliferation. It also is caused by gain-of-function mutations in FGFR3, albeit ones that are distinct from those that cause achondroplasia. It occurs in about 1 of every 20,000 live births. Affected individuals have micromelic shortening of the limbs, frontal bossing, relative macrocephaly, a small chest cavity, and a bell-shaped abdomen. The underdeveloped thoracic cavity leads to respiratory insufficiency, and these individuals usually die at birth or soon thereafter."
        },
        {
            "id": "Obstentrics_Williams_1730",
            "title": "Obstentrics_Williams",
            "content": "Mosaicism confined to the gonads likely arises from a mitotic error in cells destined to become the gonad, resulting in a population of abnormal germ cells. Because spermatogonia and oogonia divide throughout fetal life, and spermatogonia continue to divide throughout adulthood, gonadal mosaicism may also follow a meiotic error in previously normal germ cells. Gonadal mosaicism can account for de novo diseases in the ofspring of normal parents. Autosomal dominant examples are achondroplasia and osteogenesis imperfecta, and X-linked ones include Duchenne muscular dystrophy. Gonadal mosaicism also explains the 6-percent recurrence risk after the birth of a child with a disease caused by a \"new\" mutation."
        },
        {
            "id": "InternalMed_Harrison_28977",
            "title": "InternalMed_Harrison",
            "content": "Molecular Defects Mutations in the COL2A1 gene for the type II collagen of cartilage are found in a fraction of patients with both mild and severe CDs. For example, a mutation in the gene substituting a cysteine residue for an arginine was found in three unrelated families with spondyloepiphyseal dysplasia (SED) and precocious generalized osteoarthritis (OA). Mutations in the gene, often glycine substitution mutations with the collagen II triple helix, were also found in some lethal CDs characterized by gross deformities of bones and cartilage, such as those found in spondyloepiphyseal dysplasia congenita, spondyloepimetaphyseal dysplasia congenita, hypochondrogenesis/achondrogenesis type II, and Kniest\u2019s syndrome. The highest incidence of COL2A1 mutations, however, occurs in patients with the distinctive features of Stickler\u2019s syndrome, which is characterized by skeletal changes, orofacial abnormalities, and auditory abnormalities. Most of the mutations in COL2A1 are premature stop"
        },
        {
            "id": "Pediatrics_Nelson_954",
            "title": "Pediatrics_Nelson",
            "content": "ACH is caused by mutations in the FGFR3 gene. Early in development, FGFR3 is expressed during endochondral bone formation. More than 95% of cases of ACH are caused by one of two mutations in the same base pair (site 1138). This site, extremely active for mutations, is known as a mutational hot spot. As they grow, children with ACH often develop associated medical and psychological problems. Hydrocephalus and central apnea may occur because of narrowing of the foramen magnum and compression of the brainstem and may present a life-threatening complication in infancy. Bowing of the legs may occur later in childhood because of unequal growth of the tibia and fibula. Dental malocclusion, obstructive apnea, and hearing loss due to middle ear dysfunction are common in later childhood. During later childhood and adolescence, the psychological effects of the short stature may manifest. In adulthood, further complications include compression of"
        },
        {
            "id": "InternalMed_Harrison_28969",
            "title": "InternalMed_Harrison",
            "content": "Molecular Defects Subsets of patients with different types of EDS have mutations in the structural genes for collagens (Table 4273). These include mutations in the COL1A1 gene in a few patients with moderately severe classical EDS (type I); mutations in COL1A2 in rare patients with an aortic valvular form of EDS; mutations in two of the three genes (COL5A1 and COL5A2) for type V collagen, a minor collagen found in association with type I collagen, in about half the patients with classical EDS (types I and II); and mutations in the COL3A1 gene for type III collagen, which is abundant in the aorta in patients with the frequently lethal vascular EDS (type IV). Some of the type I collagen-related mutations alter processing of the protein or genes for the processing enzymes. Arthrochalasic EDS (type"
        },
        {
            "id": "First_Aid_Step1_506",
            "title": "First_Aid_Step1",
            "content": "462 SECTION III MUSCULOSKELETAL, SKIN, AND CONNECTIVE TISSUE ` pathology Achondroplasia Failure of longitudinal bone growth (endochondral ossification) \u008e short limbs. Membranous ossification is not affected \u008e large head relative to limbs. Constitutive activation of fibroblast growth factor receptor (FGFR3) actually inhibits chondrocyte proliferation. > 85% of mutations occur sporadically; autosomal dominant with full penetrance (homozygosity is lethal). Associated with \u008f paternal age. Most common cause of short-limbed dwarfism. Trabecular (spongy) and cortical bone lose mass despite normal bone mineralization and lab values (serum Ca2+ and PO43\u2212). Most commonly due to \u008f bone resorption related to \u0090 estrogen levels and old age. Can be 2\u00b0 to drugs (eg, steroids, alcohol, anticonvulsants, anticoagulants, thyroid replacement therapy) or other conditions (eg, hyperparathyroidism, hyperthyroidism, multiple myeloma, malabsorption syndromes, anorexia)."
        },
        {
            "id": "InternalMed_Harrison_28978",
            "title": "InternalMed_Harrison",
            "content": "the distinctive features of Stickler\u2019s syndrome, which is characterized by skeletal changes, orofacial abnormalities, and auditory abnormalities. Most of the mutations in COL2A1 are premature stop codons that produce haploinsufficiency. In addition, some patients with Stickler\u2019s syndrome or a closely related syndrome have mutations in two genes specific for type XI collagen, which is an unusual heterotrimer formed from \u03b1 chains encoded by the gene for type II collagen (COL2A1) and two distinctive genes for type XI collagen (COL11A1 and COL11A2). Mutations in the COL11A1 gene are also found in patients with Marshall\u2019s syndrome, which is similar to classic Stickler\u2019s syndrome, but with more severe hearing loss and dysmorphic features, such as a flat or retracted midface with a flat nasal bridge, short nose, anteverted nostrils, long philtrum, and large-appearing eyes."
        },
        {
            "id": "InternalMed_Harrison_28992",
            "title": "InternalMed_Harrison",
            "content": "Molecular Defects More than 90% of patients clinically classified as having MFS by the \u201cGhent criteria\u201d have a mutation in the gene for fibrillin-1 (FBN1). Mutations in the same gene are found in a few patients who do not meet the Ghent criteria. Also, a few MFS patients without mutations in the FBN1 gene have mutations in the gene for TGF-\u03b2 receptor 2 (TGFBR2). In addition, mutations in either TGFBR2 or TGFBR1 are found in the related Loeys-Dietz syndrome, which is characterized by aortic aneurysms, cleft palate, and hypertelorism. Mutations in the FBN2 gene, which is structurally similar to the FBN1 gene, are found in patients with MFS-like syndrome of congenital contractual arachnodactyly."
        },
        {
            "id": "Obstentrics_Williams_1737",
            "title": "Obstentrics_Williams",
            "content": "Paternal age older than 40 is associated with increased risk for spontaneous genetic mutations, particularly single base substitutions. This may result in ofspring with new autosomal dominant disorders or X-linked carrier states. In particular, advanced paternal age has been associated with mutations in the ibroblast growth actor receptor 2 (FGF2) gene, which may cause craniosynostosis syndromes such as Apert, Crouzon, and Pfei fer syndromes; mutations in the FGF3 gene, which may result in the ET proto-oncogene, which may cause multiple endo crine neoplasia syndromes Qung, 2003; Toriello, 2008). Using whole genome sequencing, described later (p. 272), Kong and utes to a rise in the rate of single-nucleotide polymorphisms among ofspring. his rate is approximately two mutations for each year of paternal age. Because individual autosomal domi nant disorders are uncommon, the actual risk for any speciic condition is low, and no screening or testing is speciically rec ommended."
        },
        {
            "id": "Neurology_Adams_7987",
            "title": "Neurology_Adams",
            "content": "Dwarfism can refer to either proportional or to non-proportional short stature. In proportional short stature in adults (generally, less than 147 cm, or 4 ft and 10 in), there is uniform reduction in body size that is either the result of an inherited trait (parental short stature), an endocrinopathy like growth hormone deficiency, or malnutrition during development. In disproportional short stature, the torso or extremities are selectively shortened and the underlying cause is achondroplasia (resulting from a mutation in FGFR3, and the cause of about 70 percent of cases of dwarfism) or another connective tissue disorder. In proportional dwarfism, cognition is normal whereas in disproportional dwarfism, cognitive ability can vary widely. It should be commented that a majority of severely cognitively delayed patients within this group of short stature fall well below average for height and weight, but there is a small group whose fully attained height is below 135 cm (4 ft and 6 in)"
        },
        {
            "id": "Pathology_Robbins_1479",
            "title": "Pathology_Robbins",
            "content": "http://ebooksmedicine.net There are several types of genetic abnormalities that affect the structure and function of proteins, disrupting cellular homeostasis and contributing to disease. The term mutation refers to permanent changes in the DNA. Those that affect germ cells are transmitted to the progeny and may give rise to inherited diseases. Mutations in somatic cells are not transmitted to the progeny but are important in the causation of cancers and some congenital malformations. Details of specific mutations and their effects are discussed along with the relevant disorders throughout this book. Cited here are some common examples of gene mutations and their effects:"
        },
        {
            "id": "InternalMed_Harrison_4813",
            "title": "InternalMed_Harrison",
            "content": "Polymorphisms are sequence variations that have a frequency of at least 1%. Usually, they do not result in a perceptible phenotype. Often they consist of single base-pair substitutions that do not alter the protein coding sequence because of the degenerate nature of the genetic code (synonymous polymorphism), although it is possible that some might alter mRNA stability, translation, or the amino acid sequence (nonsynonymous polymorphism) (Fig. 82-10). The detection of sequence variants poses a practical problem because mutations is much greater in the male germline than the female germline, in which rates of aneuploidy are increased (Chap. 83e). Thus, the incidence of new point mutations in spermatogonia increases with paternal age (e.g., achondrodysplasia, Marfan\u2019s syndrome, neurofibromatosis). It is estimated that about 1 in 10 sperm carries a new deleterious mutation. The rates for new mutations are calculated most readily for autosomal dominant and X-linked disorders and are"
        },
        {
            "id": "InternalMed_Harrison_28981",
            "title": "InternalMed_Harrison",
            "content": "pathology in other CDs (and in other connective tissues disorders) where gene mutations lead to protein structural abnormalities. Some patients have mutations in genes for proteins that interact with collagens. Patients with pseudoachondroplasia or autosomal dominant multiple epiphyseal dysplasia have mutations in the gene for the cartilage oligomeric matrix protein (COMP), a protein that interacts with both collagens and proteoglycans in cartilage. However, some families with multiple epiphyseal dysplasia have a defect in one of the three genes for type IX collagen (COL9A1, COL9A2, and COL9A3) or in matrilin-3, another extracellular protein found in cartilage. With misfolding mutations in COMP and matrilin-3, the activation of the UPR has been described, providing further evidence that the UPR is a component of pathology of these conditions. Some CDs are caused by mutations in genes that affect early development of cartilage and related structures. The most common form of"
        },
        {
            "id": "InternalMed_Harrison_28979",
            "title": "InternalMed_Harrison",
            "content": "Heritable Disorders of Connective Tissue 2512 CDs are also caused by mutations in the less abundant collagens found in cartilage. For example, patients with Schmid metaphyseal CD have mutations in the gene for type X collagen, a short, network-forming collagen found in the hypertrophic zone of endochondral cartilage. The syndrome is characterized by short stature, coxa vara, flaring metaphyses, and waddling gait. As with other collagen genes, the most common mutations are of two types: nonsense mutations that lead to haploinsufficiency and structural mutations that compromise collagen assembly. In type X collagen, all the structural mutations detected occur in the C-terminal NC1 domain that coordinates the formation of the trimers. This NC1 domain is functionally equivalent to the C-propeptide of the fibrillar collagens. These mutations disturb the structure of the NC1 domain, leading to misfolding and initiation of cellular ER stress via the unfolded protein response (UPR). While the"
        },
        {
            "id": "Cell_Biology_Alberts_2382",
            "title": "Cell_Biology_Alberts",
            "content": "Mutations that give rise, in a reproducible way, to rare but clearly defined abnormalities, such as albinism, hemophilia, or congenital deafness, can often be identified by studies of affected families. Such single-gene, or monogenic, disorders are often referred to as Mendelian because their pattern of inheritance is easy to track. Moreover, individuals who inherit the causative mutation will exhibit the abnormality irrespective of environmental factors such as diet or exercise. But for many common diseases, the genetic roots are more complex. Instead of a single allele of a single gene, such disorders stem from a combination of contributions from multiple genes. And often, environmental factors have strong influences on the severity of the disorder. For these multigenic conditions, such as diabetes or arthritis, population studies are often helpful in tracking down the genes that increase the risk of getting the disease."
        },
        {
            "id": "Cell_Biology_Alberts_6005",
            "title": "Cell_Biology_Alberts",
            "content": "We have already seen how some signals act systemically as hormones to regulate the development of the animal as a whole. Some of these serve to regulate growth. In mammals, for instance, growth hormone (GH) is secreted by the pituitary gland into the bloodstream and stimulates growth throughout the body: excessive production of growth hormone leads to gigantism, and too little leads to dwarfism (Figure 21\u201361). Pituitary dwarfs have bodies and organs that are proportionately small, unlike achondroplastic dwarfs, for example, whose limbs are disproportionately short, usually because of a mutation in a gene encoding an FGF receptor that disrupts normal cartilage development (Figure 21\u201362)."
        },
        {
            "id": "Pathology_Robbins_1531",
            "title": "Pathology_Robbins",
            "content": "Since the CFTR gene was cloned in 1989, more than 1800 disease-causing mutations have been identified. They can be classified on the basis of clinical course of CF or the nature of the underlying defect. Mechanistically, they may result in reduced quantity of functional CFTR that reaches the cell surface or reduced function of CFTR that reaches the cell surface. As we shall see these differences impact on the development of treatment strategies. They can also be classified as severe or mild, depending on the clinical phenotype. Severe mutations are associated with complete loss of CFTR protein function, whereas mild mutations allow some residual function. The most common severe CFTR mutation is a deletion of three nucleotides coding for phenylalanine at amino acid position 508 (\u0394F508). This causes misfolding and total loss of the CFTR. Worldwide, \u0394F508 mutation is found in approximately 70% of patients with CF. Since CF is an autosomal recessive disease, affected persons harbor"
        },
        {
            "id": "InternalMed_Harrison_28466",
            "title": "InternalMed_Harrison",
            "content": "PTHrP exerts important developmental influences on fetal bone development and in adult physiology. A homozygous ablation of the gene encoding PTHrP (or disruption of the PTH1R gene) in mice causes a lethal phenotype in which animals are born with pronounced acceleration of chondrocyte maturation that resembles a lethal form of chondrodysplasia in humans that is caused by homozygous or compound heterozygous, inactivating PTH1R mutations (Fig. 424-2). Heterozygous PTH1R mutations in humans furthermore can be a cause of delayed tooth eruption, and mice that are heterozygous for ablation of the PTHrP gene display reduced mineral density consistent with osteoporosis. Experiments with these mouse models point to a hitherto unappreciated role of PTHrP as a paracrine/autocrine factor that modulates bone metabolism in adults as well as during bone development."
        },
        {
            "id": "InternalMed_Harrison_27413",
            "title": "InternalMed_Harrison",
            "content": "Testicular morphology, semen production, and fertility are maintained up to a very old age in men. Although concern has been expressed about age-related increases in germ cell mutations and impairment of DNA repair mechanisms, there is no clear evidence that the frequency of chromosomal aneuploidy is increased in the sperm of older men. However, the incidence of autosomal dominant diseases, such as achondroplasia, polyposis coli, Marfan\u2019s syndrome, and Apert\u2019s syndrome, increases in the offspring of men who are advanced in age, consistent with transmission of sporadic missense mutations. Advanced paternal age may be associated with increased rates of de novo mutations, which may contribute to an increased risk of neurodevelopmental diseases such as schizophrenia and autism. The somatic mutations in male germ cells that enhance the proliferation of germ cells could lead to within-testis expansion of mutant clonal lines, thus favoring the propagation of germ cells carrying these"
        },
        {
            "id": "InternalMed_Harrison_28917",
            "title": "InternalMed_Harrison",
            "content": "in different connective tissues and the collagen genes were readily isolated by their unique signature sequences. Also, the collagen genes are particularly vulnerable to a large number different mutations because of unusual structural requirements of the protein. The search for mutations in collagen genes proved fruitful in that mutations were found in most patients with OI, in many patients with hyperextensible skin, in some patients with dwarfism, and in patients with other disorders, including Alport\u2019s syndrome, that were not initially classified as disorders of connective tissue. Also, mutations in collagen genes were found in subset of patients with a diagnosis of osteoarthritis and a subset of patients with the diagnosis of osteoporosis. However, the search for mutations quickly expanded to hundreds of other genes that included those for other structural proteins, for the posttranslational processing of structural proteins, and for growth factors and their receptors, and other"
        },
        {
            "id": "Pathology_Robbins_1633",
            "title": "Pathology_Robbins",
            "content": "Three groups of diseases resulting from mutations affecting single genes do not follow the mendelian rules of inheritance: Diseases associated with alteration of imprinted regions of the genome Fragile X syndrome is the prototype of diseases in which the causative mutation occurs in a long repeating sequence of three nucleotides. Other examples of diseases associated with trinucleotide repeat mutations are Huntington disease and myotonic dystrophy. This type of mutation is now known to cause about 40 diseases, and all disorders discovered so far are associated with neurodegenerative changes. In each of these conditions, amplification of specific sets of three nucleotides within the gene disrupts its function. Certain unique features of trinucleotide repeat mutations, described later, are responsible for the atypical pattern of inheritance of the associated diseases."
        },
        {
            "id": "InternalMed_Harrison_4829",
            "title": "InternalMed_Harrison",
            "content": "Functional Consequences of Mutations Functionally, mutations can be broadly classified as gain-of-function and loss-of-function mutations. Gain-of-function mutations are typically dominant (e.g., they result in phenotypic alterations when a single allele is affected). Inactivating mutations are usually recessive, and an affected individual is homozygous or compound heterozygous (e.g., carrying two different mutant alleles of the same gene) for the disease-causing mutations. Alternatively, mutation in a single allele can result in haploinsufficiency, a situation in which one normal allele is not sufficient to maintain a normal phenotype. Haploinsufficiency is a commonly observed mechanism in diseases associated with mutations in transcription factors (Table 82-2). Remarkably, the clinical features among patients with an identical mutation in a transcription factor often vary significantly. One mechanism underlying this variability consists in the influence of modifying genes."
        }
    ],
    "scores": [
        0.03941170816110737,
        0.03884761179586597,
        0.03840749009224166,
        0.037635159268759946,
        0.03732198486871384,
        0.033479607565833326,
        0.03251080760330528,
        0.027610189374895257,
        0.027485348715903163,
        0.027294512341241313,
        0.02654798259619219,
        0.024803816231359025,
        0.024153713866742667,
        0.022880401444072364,
        0.022340931379832982,
        0.021808777704280465,
        0.02038308869033805,
        0.02009241979916467,
        0.018929968729783943,
        0.0178585665311329,
        0.017150346086694496,
        0.016802587176602924,
        0.016698735568993952,
        0.01649470540320391,
        0.016083376222336594,
        0.016066589237320947,
        0.015621244893054553,
        0.015546218487394958,
        0.01552757793764988,
        0.015504807692307693,
        0.015460335842501447,
        0.015378435760601366
    ],
    "execution_time": 57.50369071960449
}